MBC and SBT tests have been performed for decades, yet
there is still no consensus as to their clinical utility in direct
patient care. Opinions differ on the use of such in vitro
susceptibility tests, from those who would eliminate routine MBC testing (38) to those who consider that lack of standardization
should not interfere with the performance and
interpretation of MBC tests by clinical microbiologists and
their use by clinicians for making decisions about therapy